You are here: Home » Companies » Financial X-Ray
Bharat Biotech signs deal with Brazilian wholesaler to supply Covaxin
Byju's to pay $1 billion for Blackstone-backed Aakash Educational Services
Business Standard

Testing recovery gains factored in Thyrocare Technologies stock

Margin pressures and valuations would limit major upsides

Topics
Thyrocare Technologies | Health sector | Lockdown

Ram Prasad Sahu  |  Mumbai 



Healthcare
The growth is slightly lower than analyst expectations which had pegged around the 40 per cent mark.

The stock of gained nearly 4 per cent in early trade (1 per cent higher at close) after the company indicated a recovery in non-Covid business in the quarter. Recovery in overall testing volumes is expected to help the company post a 34 per cent year-on-year (YoY) growth in revenues in Q3.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, January 12 2021. 19:51 IST

RECOMMENDED FOR YOU

.